Monoamine Oxidase Inhibitors (MAOIs): Phenylephrine exerts its vasoconstricting properties by stimulating adrenergic receptors and displacing norepinephrine from neuronal storage sites. Since MAOIs impede the metabolism of sympathomimetic amines and increase the store of releasable norepinephrine in adrenergic nervous tissue, MAOIs may potentiate the pressor effect of phenylephrine.
Warfarin-like Compounds: For most patients, occasional use of paracetamol generally has little or no effect on the INR in patients on chronic warfarin therapy; however, there has been controversy regarding the possibility of paracetamol potentiating the anticoagulant effects of warfarin and other coumarin derivatives. Consumers should be instructed to ask a physician or pharmacist before use if they are taking the blood thinning drug warfarin or other coumarin derivatives.
Flucloxacillin: High anion gap metabolic acidosis from pyroglutamic acid (5-oxoprolinemia) has been reported with concomitant use of therapeutic doses of paracetamol and flucloxacillin. Patients reported to be most at risk are elderly females with underlying disease such as sepsis, renal function abnormality, and malnutrition. Most patients improve after stopping one or both of the drugs. Consumers should be instructed to ask their healthcare provider before use if they are taking the antibiotic flucloxacillin.
Sinutab Cold Plus: CNS Depressants (Alcohol, Sedatives, Tranquilizers): Chlorpheniramine may enhance the sedative effects of central nervous system depressants, including alcohol, sedatives, and tranquilizers.
Other Services
Country
Support
Account
Sign Out